CTRI/2014/12/005261招募中4 期
Effectiveness and safety of levocetirizine 10 mg versus combination of levocetirizine 5 mg plus montelukast 10 mg in chronic urticaria resistant to levocetirizine 5mg: A double blind, randomised, controlled, trial - LMRCT
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients presenting with chronic urticaria aged above 18 years and symptoms not responding to a single daily dose of second generation antihistamine (levocetirizine 5mg once daily dose) even after 2 weeks of therapy.
排除标准
- •1.Pregnant and lactating females.
- •2.Patients having immunosuppression due to drug or disease.
- •3.Patients having end stage renal disease.
- •4.Patients allergic to levocetirizine, cetrizine or its parent compound hydroxyzine, montelukast.
- •5.Patients not consenting.
研究者
相似试验
进行中（未招募）
1 期
Efficacy and safety of levocetirizine alone or in combination with tranexamic acid in the treatment of spontaneous chronic urticaria.Chronique Spontaneous urticariaEUCTR2018-003139-31-FRCHU GRENOBLE ALPES80
进行中（未招募）
不适用
Evaluation of a treatment with levocetirizine in children allergic to mites suffering for recurrent respiratory infections with or without concomitant asthma symptoms - NDEUCTR2006-006379-19-ITISTITUTO GIANNINA GASLINI
尚未招募
不适用
Comparing efficacy of different antihistamines in Urticaria.CTRI/2021/04/033119AIIMS Jodhpur
尚未招募
4 期
Comparison of levocetrizine and bilastine for treatment of childhood transient red itchy skin rashCTRI/2022/02/040106IMS and SUM Hospital Bhubaneswar
已完成
3 期
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown OriginChronic UrticariaAllergic RhinitisNCT00619801UCB Pharma173